翻訳と辞書
Words near each other
・ Hyperelliptic curve cryptography
・ Hyperelliptic surface
・ Hyperemesis gravidarum
・ Hyperenor
・ Hypereosinophilia
・ Hypereosinophilic syndrome
・ Hyperepia
・ Hyperes
・ Hyperesthesia
・ Hyperestrogenism
・ Hyperetes
・ Hyperetis
・ Hypereutectic piston
・ Hyperexponential distribution
・ Hyperextension (exercise)
Hyperfibrinolysis
・ Hyperfine structure
・ Hyperfinite
・ Hyperfinite set
・ Hyperfinite type II factor
・ Hyperflex
・ Hyperfocal distance
・ Hyperfocus
・ HyperFont
・ Hyperforeignism
・ Hyperforin
・ Hyperfrontia
・ HyperFun
・ Hyperfunction
・ Hypergammaglobulinemia


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Hyperfibrinolysis : ウィキペディア英語版
Hyperfibrinolysis
The fibrinolysis system is responsible for removing blood clots. Hyperfibrinolysis describes a situation with markedly enhanced fibrinolytic activity, resulting in increased, sometimes catastrophic bleeding. Hyperfibrinolysis can be caused by acquired or congenital reasons. Among the congenital conditions for hyperfibrinolysis, deficiency of alpha-2-antiplasmin〔Carpenter SL, Mathew P. Alpha-2-antiplasmin and its deficiency: fibrinolysis out of balance. Haemophilia, 2008;14:1250-4〕 (alpha-2-plasmin inhibitor) or plasminogen activator inhibitor type 1 (PAI-1)〔Takahashi Y, Tanaka T, Minowa H et al. Hereditary partial deficiency of plasminogen activator inhibitor 1 associated with a lifelong bleeding tendency. Int J Hematol 1996;64:61-8〕 are very rare. The affected individuals show a hemophilia-like bleeding phenotype. Acquired hyperfibrinolysis is found in liver disease,〔Goerlinger K. Coagulation management during liver transplantation. Haemostaseologie 2006;26 (3 Suppl 1):S64-76〕 in patients with severe trauma,〔Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth. 2008;100:792-7〕 during major surgical procedures,〔Vanek T, Jares M, Snircova J, Maly M. Fibrinolysis in coronary artery surgery: detection by thrombelastography. Interact Cardiovasc Thorac Surg. 2007;6:700-4〕 and other conditions. A special situation with temporarily enhanced fibrinolysis is thrombolytic therapy with drugs which activate plasminogen, e.g. for use in acute ischemic events or in patients with stroke. In patients with severe trauma, hyperfibrinolysis is associated with poor outcome.〔Schöchl H. Hyperfibrinolysis:a prognostic marker of poor survival following major trauma? Haemostaseologie 2008;28:A57(P-04-11)〕
Bleeding is caused by the generation of fibrinogen degradation products which interfere with regular fibrin polymerization and inhibit platelet aggregation. Moreover, plasmin which is formed in excess in hyperfibrinolysis can proteolytically activate or inactivate many plasmatic or cellular proteins involved in hemostasis. Especially the degradation of fibrinogen, an essential protein for platelet aggregation and clot stability, may be a major cause for clinical bleeding.
==Diagnosis==

The diagnosis of hyperfibrinolysis is made indirectly with immunochemical methods which detect the elevation of biomarkers such as D-Dimer (cross-linked fibrin degradation products), fibrinogen split products (FSP), complexes of plasmin and alpha-2-antiplasmin (PAP). However, the sensitivity and specificity of these methods is limited because elevation of these biomarkers can also occur induced in other clinical conditions. The classical coagulation tests such as PT (prothrombin time), aPTT (activated partial thromboplastin time) or thrombin time are not very sensitive for hyperfibrinolysis, and influenced by numerous other variables. The euglobulin lysis time test is very time consuming and complex. Viscoelastic methods in whole blood, especially thromboelastometry (TEM) when performed with special reagents detect hyperfibrinolysis very sensitively in a functional approach. The APTEM test, a tissue factor activated, heparin insensitive test performed in the presence of aprotinin (fibrinolysis inhibitor, confirms hyperfibrinolysis by comparing the TEM result of this assay with the EXTEM test (same activator, but without aprotinin). A normalization or improvement of the TEMogram in APTEM versus EXTEM confirms hyperfibrinolysis.〔Vorweg M, Hartmann B, Knüttgen D, Jahn MC, Doehn M. Management of fulminant fibrinolysis during abdominal aortic surgery. J Cardiothorac Vasc Anesth 2001;15:764〕 This in vitro approach can predict to a certain level if normal clot formation can be restored by use of an antifibrinolytic drug.

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Hyperfibrinolysis」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.